Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 26, 2002 - Issue 4
49
Views
2
CrossRef citations to date
0
Altmetric
Original

POLAR BEAR HEMOGLOBIN AND HUMAN Hb A0: SAME 2,3-DIPHOSPHOGLYCERATE BINDING SITE BUT ASYMMETRY OF THE BINDING?

, , , , , , , & show all
Pages 363-371 | Received 12 Jun 2002, Accepted 05 Jul 2002, Published online: 07 Jul 2009
 

Abstract

Polar bear (Ursus maritimus) hemoglobin (Hb) shows a low response to 2,3-diphosphoglycerate (2,3-DPG), compared to human Hb A0, even though these proteins have the same 2,3-DPG-binding site. In addition, polar bear Hb shows a high response to chloride and an alkaline Bohr effect (Δlog P50/ΔpH) that is significantly greater than that of human Hb A0. The difference in sequence Pro (Hb A0)→Gly (polar bear Hb) at position A2 in the A helix seems to be critical for reduced binding of 2,3-DPG. Our results also show that the A2 position may influence not only the flexibility of the A helix, but that differences in flexibility of the first turn of the A helix may affect the unloading of oxygen for the intrinsic ligand affinities of the α and β chains. However, preferential binding to either chain can only take place if there is appreciable asymmetric binding of the phosphoric effector. Regarding this point, 31P NMR data suggest a loss of symmetry of the 2,3-DPG-binding site in the deoxyHb–2,3-DPG complex.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.